Infinity Pharmaceuticals

Infinity Pharmaceuticals Working Capital Turnover

Working Capital Turnover of Infinity Pharmaceuticals (INFIQ) as of Nov 20, 2026.

Working Capital Turnover

-

Last updated:

Working Capital Turnover of Infinity Pharmaceuticals is 2026 - . Working Capital Turnover of Infinity Pharmaceuticals was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Infinity Pharmaceuticals stock

On Eulerpool you can find the complete historical development of Working Capital Turnover Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Working capital turnover measures how efficiently a company uses its working capital to generate revenue. Higher ratios indicate more efficient short-term asset utilization.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Working Capital Turnover's Infinity Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

To evaluate Working Capital Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Working Capital Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Infinity Pharmaceuticals

All Key Metrics — Infinity Pharmaceuticals